Manish Kumar

Manish Kumar

Auto-generated profile, based on publicly available information

Manish Kumar

Department of Neurosurgery, Medical College of Georgia, Augusta University (MCG-AU), Augusta, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2014 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
TATanvir Ahmad
Tanvir Ahmad
SMShravani Mukherjee
Shravani Mukherjee
BPBijay Pattnaik
Bijay Pattnaik
MKManish Kumar
Manish Kumar
SSSuchita Singh
Suchita Singh
AAAnurag Agrawal
Anurag Agrawal

1 November 2011 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
MKManish Kumar
Manish Kumar
TATanvir Ahmad
Tanvir Ahmad
ASAmit Sharma
Amit Sharma
UMUlaganathan Mabalirajan
Ulaganathan Mabalirajan
AKAnkur Kulshreshtha
Ankur Kulshreshtha
BGBalaram Ghosh
Balaram Ghosh

7 April 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ASAmit Sharma
Amit Sharma
MKManish Kumar
Manish Kumar
JAJyotirmoi Aich
Jyotirmoi Aich
MHManoj Hariharan
Manoj Hariharan
SBSamir K. Brahmachari
Samir K. Brahmachari
BGBalaram Ghosh
Balaram Ghosh
IL-10 is a key regulator of the immune system that critically determines health and disease. Its expression is finely tuned both at the transcriptional and posttranscriptional levels. Although the importance of posttranscriptional regulation of IL-10 has been previously shown, understanding the underlying mechanisms is still in its infancy. In this study, using a combination of bioinformatics and molecular approaches, we report that microRNA (hsa-miR-106a) regulates IL-10 expression. The hsa-miR-106a binding site in the 3′ UTR of IL10 has been identified by site-directed mutagenesis studies. Also, the involvement of transcription factors, Sp1 and Egr1, in the regulation of hsa-miR-106a expression and concomitant decrease in the IL-10 expression, has also been demonstrated. In summary, our results showed that IL-10 expression may be regulated by miR-106a, which is in turn transcriptionally regulated by Egr1 and Sp1.

1 May 2014 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
SDSudipta Das
Sudipta Das
MKManish Kumar
Manish Kumar
VNVinny Negi
Vinny Negi
BPBijay Pattnaik
Bijay Pattnaik
YPY. S. Prakash
Y. S. Prakash
BGBalaram Ghosh
Balaram Ghosh
Idiopathic pulmonary fibrosis (IPF) is a fatal disorder resulting from the progressive remodeling of lungs, with no known effective treatment. Although transforming growth factor (TGF)-β has a well-established role in lung fibrosis, clinical experience with neutralizing antibodies to TGF-β has been disappointing, and strategies to directly suppress TGF-β1 secretion are needed. In this study we used a combination of in silico, in vitro, and in vivo approaches to identify microRNAs involved in TGF-β1 regulation and to validate the role of miR-326 in pulmonary fibrosis.We show that hsa-miR-326 regulates TGF-β1 expression and that hsa-miR-326 levels are inversely correlated to TGF-β1 protein levels in multiple human cell lines. The increase in TGF-β1 expression during the progression of bleomycin-induced lung fibrosis in mice was associated with loss of mmu-miR-326. Restoration of mmu-miR-326 levels by intranasal delivery of miR-326 mimics was sufficient to inhibit TGF-β1 expression and attenuate the fibrotic response. Moreover, human IPF lung specimens had markedly diminished miR-326 expression as compared with nonfibrotic lungs. Additional targets of miR-326 controlling TGF-β signaling and fibrosis-related pathways were identified, and miR-326 was found to down-regulate profibrotic genes, such as Ets1, Smad3, and matrix metalloproteinase 9, whereas it up-regulates antifibrotic genes, such as Smad7. Our results suggest for the first time that miR-326 plays a key role in regulating TGF-β1 expression and other profibrotic genes and could be useful in developing better therapeutic strategies for alleviating lung fibrosis.

1 February 2018 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
MBMolly Braun
Molly Braun
ZKZenab T. Khan
Zenab T. Khan
MKMohammad B. Khan
Mohammad B. Khan
MKManish Kumar
Manish Kumar
AWAyobami Ward
Ayobami Ward
Kumar VaibhavKumar Vaibhav
Kumar Vaibhav

27 February 2013 in Scientific Reports
Verified
Journal Article
Open access
UMUlaganathan Mabalirajan
Ulaganathan Mabalirajan
RRRakhshinda Rehman
Rakhshinda Rehman
TATanvir Ahmad
Tanvir Ahmad
SKSarvesh Kumar
Sarvesh Kumar
SSSuchita Singh
Suchita Singh
BGBalaram Ghosh
Balaram Ghosh
Airway epithelial injury is the hallmark of various respiratory diseases, but its mechanisms remain poorly understood. While 13-S-hydroxyoctadecadienoic acid (13-S-HODE) is produced in high concentration during mitochondrial degradation in reticulocytes little is known about its role in asthma pathogenesis. Here, we show that extracellular 13-S-HODE induces mitochondrial dysfunction and airway epithelial apoptosis. This is associated with features of severe airway obstruction, lung remodeling, increase in epithelial stress related proinflammatory cytokines and drastic airway neutrophilia in mouse. Further, 13-S-HODE induced features are attenuated by inhibiting Transient Receptor Potential Cation Channel, Vanilloid-type 1 (TRPV1) both in mouse model and human bronchial epithelial cells. These findings are relevant to human asthma, as 13-S-HODE levels are increased in human asthmatic airways. Blocking of 13-S-HODE activity or disruption of TRPV1 activity attenuated airway injury and asthma mimicking features in murine allergic airway inflammation. These findings indicate that 13-S-HODE induces mitochondrial dysfunction and airway epithelial injury.